{"transactions":[{"id":1928506,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-04-04T21:02:33.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16278,"price":6.84,"value":111341.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,316 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":116361,"source":{"system":"sec-edgar","filing":"0001140361-23-016457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000114036123016457/form4.xml","form_type":"4"}},{"id":2047532,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-24T16:47:09.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":131323,"source":{"system":"sec-edgar","filing":"0001567619-23-001209","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761923001209/doc1.xml","form_type":"4"}},{"id":2055682,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-12T16:37:50.000Z","date":"2023-01-11","kind":"tax_withholding","acquired":false,"shares":3602,"price":10.26,"value":36956.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":91323,"source":{"system":"sec-edgar","filing":"0001567619-23-000892","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761923000892/doc1.xml","form_type":"4"}},{"id":2055681,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-12T16:37:50.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":3602,"price":9.85,"value":35479.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":94925,"source":{"system":"sec-edgar","filing":"0001567619-23-000892","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761923000892/doc1.xml","form_type":"4"}},{"id":2060524,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T18:15:45.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":9.87,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-23-000696","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761923000696/doc1.xml","form_type":"4"}},{"id":2060523,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-06T18:15:45.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":5437,"price":9.87,"value":53663.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":98527,"source":{"system":"sec-edgar","filing":"0001567619-23-000696","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761923000696/doc1.xml","form_type":"4"}},{"id":2304735,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-05T17:19:29.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":3458,"price":12.85,"value":44435.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."}],"balance_after":103963,"source":{"system":"sec-edgar","filing":"0001567619-22-008113","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761922008113/doc1.xml","form_type":"4"}},{"id":2436886,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-12T16:39:16.000Z","date":"2022-01-11","kind":"tax_withholding","acquired":false,"shares":3583,"price":14.36,"value":51451.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock withheld to pay the related tax liability on RSUs that vested on January 11, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 91,249 RSUs."}],"balance_after":107421,"source":{"system":"sec-edgar","filing":"0001567619-22-001114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761922001114/doc1.xml","form_type":"4"}},{"id":2436885,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-12T16:39:16.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":4150,"price":14.3,"value":59345.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units (\"RSUs\") that vested on January 10, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 101,666 RSUs."}],"balance_after":111004,"source":{"system":"sec-edgar","filing":"0001567619-22-001114","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761922001114/doc1.xml","form_type":"4"}},{"id":2441699,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T19:48:53.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-22-000819","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761922000819/doc1.xml","form_type":"4"}},{"id":2441698,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-06T19:48:53.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 4 of each year, with the first 1/3 vesting on January 4, 2023 and with the RSUs being fully vested on January 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 112,083 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,768 shares acquired on November 15, 2021, pursuant to Issuer's employee stock purchase plan."}],"balance_after":115154,"source":{"system":"sec-edgar","filing":"0001567619-22-000819","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761922000819/doc1.xml","form_type":"4"}},{"id":2734581,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-30T16:37:49.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/2 of the RSUs vest annually on April 1 of each year, with the first 1/2 vesting on April 1, 2022 and with the RSUs being fully vested on April 1, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 72,083 RSUs."}],"balance_after":73386,"source":{"system":"sec-edgar","filing":"0001567619-21-008803","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921008803/doc1.xml","form_type":"4"}},{"id":2794848,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":57812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":17188,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":57812},"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794847,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":20312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 15, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":4688,"derivative":{"exercise_price":9.3,"expiration_date":"2027-11-15","underlying":"Common Stock","underlying_shares":20312},"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794846,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":24356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.0838,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":24356},"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794845,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":114240,"price":16.2488,"value":1856262.912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $16.071 to $16.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":53386,"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794844,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":57812,"price":10.05,"value":581010.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":167626,"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794843,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":20312,"price":9.3,"value":188901.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":109814,"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2794842,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T17:37:31.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":24356,"price":2.0838,"value":50753.0328,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 52,083 restricted stock units."}],"balance_after":89502,"source":{"system":"sec-edgar","filing":"0001567619-21-006128","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921006128/doc1.xml","form_type":"4"}},{"id":2882127,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T17:39:18.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 22, 2021, the compensation committee of the board of directors of Coherus BioSciences, Inc. approved the grant of an option to purchase 50,000 shares of common stock subject to the achievement of a certain performance milestone. 100% of the shares underlying this option were fully vested and exercisable at grant."}],"balance_after":50000,"derivative":{"exercise_price":17.6,"exercise_date":"2021-02-01","expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-002144","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921002144/doc1.xml","form_type":"4"}},{"id":2908382,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T16:24:18.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-21-000983","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921000983/doc1.xml","form_type":"4"}},{"id":2908381,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-13T16:24:18.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 RSUs."}],"balance_after":65146,"source":{"system":"sec-edgar","filing":"0001567619-21-000983","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921000983/doc1.xml","form_type":"4"}},{"id":2909719,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-12T16:55:57.000Z","date":"2021-01-10","kind":"tax_withholding","acquired":false,"shares":4080,"price":18.18,"value":74174.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,833 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,303 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":33896,"source":{"system":"sec-edgar","filing":"0001567619-21-000923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761921000923/doc1.xml","form_type":"4"}},{"id":2948817,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":17626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":24356,"derivative":{"exercise_price":2.0838,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":17626},"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":2948816,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-09","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":41982,"derivative":{"exercise_price":2.0838,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":2948815,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":17626,"price":18.0453,"value":318066.4578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades at prices ranging from $18.00 to $18.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":36673,"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":2948814,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":17626,"price":2.0838,"value":36729.0588,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":54299,"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":2948813,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":49512,"price":18.2397,"value":903084.0264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $18.00 to $18.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":36673,"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":2948812,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T16:39:29.000Z","date":"2020-12-09","kind":"exercise","acquired":true,"shares":30000,"price":2.0838,"value":62514.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":86185,"source":{"system":"sec-edgar","filing":"0001567619-20-020979","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920020979/doc1.xml","form_type":"4"}},{"id":3311747,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T17:49:36.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 10, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-20-001040","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920001040/doc1.xml","form_type":"4"}},{"id":3311746,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:49:36.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 10 of each year, with the first 1/3 vesting on January 10, 2021 and with the RSUs being fully vested on January 10, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,038 shares acquired on May 15, 2019, pursuant to Issuer's employee stock purchase plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 31,250 RSUs."}],"balance_after":56185,"source":{"system":"sec-edgar","filing":"0001567619-20-001040","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920001040/doc1.xml","form_type":"4"}},{"id":3311745,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:49:36.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":3477,"price":17.73,"value":61647.21,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,038 shares acquired on May 15, 2019, pursuant to Issuer's employee stock purchase plan."}],"balance_after":24935,"source":{"system":"sec-edgar","filing":"0001567619-20-001040","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920001040/doc1.xml","form_type":"4"}},{"id":3311744,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:49:36.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":8900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,038 shares acquired on May 15, 2019, pursuant to Issuer's employee stock purchase plan."}],"balance_after":28412,"source":{"system":"sec-edgar","filing":"0001567619-20-001040","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000156761920001040/doc1.xml","form_type":"4"}},{"id":3695686,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option\n(Right to Buy)","published_at":"2019-01-15T16:05:55.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from\nJanuary 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":126000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0000899243-19-001200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924319001200/doc4.xml","form_type":"4"}},{"id":3695685,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T16:05:55.000Z","date":"2019-01-11","kind":"tax_withholding","acquired":false,"shares":5916,"price":12.37,"value":73180.92,"ownership":{"direct":true},"balance_after":17474,"source":{"system":"sec-edgar","filing":"0000899243-19-001200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924319001200/doc4.xml","form_type":"4"}},{"id":3695684,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T16:05:55.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":15562,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23390,"source":{"system":"sec-edgar","filing":"0000899243-19-001200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924319001200/doc4.xml","form_type":"4"}},{"id":3695687,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T10:05:00.000Z","date":"2018-11-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":12.27,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-19-001180","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924319001180/doc4a.xml","form_type":"4/A","original_submission_date":"2018-11-20"}},{"id":3696534,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-14T16:08:11.000Z","date":"2018-11-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":12.27,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-19-001121","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924319001121/doc4a.xml","form_type":"4/A","original_submission_date":"2018-11-20"}},{"id":3756807,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":114737,"kind":"person","name":"Vexler Vladimir","position":1,"cik":"0001759506","reported_name":"Vexler Vladimir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option\n(Right to Buy)","published_at":"2018-11-20T16:12:11.000Z","date":"2018-11-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":12.27,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-18-029452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759506/000089924318029452/doc4.xml","form_type":"4"}}]}